HYEX HEALTHY EXTRACTS INC. revenue, earnings and financials

For the quarter ended June 30, 2026, HEALTHY EXTRACTS INC. reported revenue of $2.07M (up 113.4% from a year earlier), net income of −$129K and diluted EPS of n/a; over the last four quarters revenue was $6.29M and net income −$879K; for the fiscal year ended December 2025 revenue was $4.51M, up 44.9% on the year before.

HYEX annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $4.51M, gross profit $2.42M, operating income n/a, net income −$881K (margin -19.5%), EPS n/a
• Fiscal year ended Dec 2024: revenue $3.11M, gross profit $1.91M, operating income n/a, net income −$841K (margin -27.0%), EPS n/a
• Fiscal year ended Dec 2023: revenue $2.49M, gross profit $1.62M, operating income n/a, net income −$2.47M (margin -99.5%), EPS n/a
• Fiscal year ended Dec 2022: revenue $2.25M, gross profit $1.37M, operating income n/a, net income −$983K (margin -43.7%), EPS n/a
• Fiscal year ended Dec 2021: revenue $1.68M, gross profit $695K, operating income n/a, net income −$1.99M (margin -118.5%), EPS n/a

HYEX quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $2.07M (up 113.4% year over year), net income −$129K, EPS n/a
• Quarter ended Mar 31, 2026: revenue $1.61M (up 73.0% year over year), net income −$201K, EPS n/a
• Quarter ended Dec 31, 2025 (from the annual report): revenue $1.69M (up 119.7% year over year), net income −$154K, EPS n/a
• Quarter ended Sep 30, 2025: revenue $918K (up 23.2% year over year), net income −$395K, EPS n/a
• Quarter ended Jun 30, 2025: revenue $969K (up 6.6% year over year), net income $67.1K, EPS n/a
• Quarter ended Mar 31, 2025: revenue $931K (up 35.2% year over year), net income −$399K, EPS n/a
• Quarter ended Dec 31, 2024 (from the annual report): revenue $771K (up 15.3% year over year), net income −$447K, EPS n/a
• Quarter ended Sep 30, 2024: revenue $745K (up 21.4% year over year), net income $354K, EPS n/a
• Quarter ended Jun 30, 2024: revenue $908K (up 54.4% year over year), net income $114K, EPS n/a
• Quarter ended Mar 31, 2024: revenue $689K (up 12.0% year over year), net income −$861K, EPS n/a
• Quarter ended Dec 31, 2023 (from the annual report): revenue $669K (down 8.4% year over year), net income −$379K, EPS n/a
• Quarter ended Sep 30, 2023: revenue $614K (up 22.8% year over year), net income −$248K, EPS n/a
• Quarter ended Jun 30, 2023: revenue $588K (up 25.3% year over year), net income −$1.27M, EPS n/a
• Quarter ended Mar 31, 2023: revenue $615K (up 11.5% year over year), net income −$579K, EPS n/a
• Quarter ended Dec 31, 2022 (from the annual report): revenue $730K (down 4.7% year over year), net income $43.4K, EPS n/a
• Quarter ended Sep 30, 2022: revenue $500K (up 31.5% year over year), net income −$170K, EPS n/a
• Quarter ended Jun 30, 2022: revenue $470K (up 92.6% year over year), net income −$859K, EPS n/a
• Quarter ended Mar 31, 2022: revenue $552K (up 223.7% year over year), net income $3.01K, EPS n/a
• Quarter ended Dec 31, 2021 (from the annual report): revenue $766K, net income $537K, EPS n/a
• Quarter ended Sep 30, 2021: revenue $380K, net income −$672K, EPS $0.00

HYEX cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $166K, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $282K, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$416K, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$391K, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$901K, share buybacks n/a

HYEX balance sheet

• Jun 30, 2026: cash n/a, total assets $32.6M, total liabilities $10.2M, shareholders' equity $22.4M
• Mar 31, 2026: cash n/a, total assets $27.3M, total liabilities $3.34M, shareholders' equity $24.0M
• Dec 31, 2025: cash n/a, total assets $27.8M, total liabilities $3.80M, shareholders' equity $24.0M
• Sep 30, 2025: cash n/a, total assets $26.2M, total liabilities $2.13M, shareholders' equity $24.1M
• Jun 30, 2025: cash n/a, total assets $2.50M, total liabilities $2.02M, shareholders' equity $478K
• Mar 31, 2025: cash n/a, total assets $2.41M, total liabilities n/a, shareholders' equity $60.5K
• Dec 31, 2024: cash n/a, total assets $2.38M, total liabilities $1.97M, shareholders' equity $152K
• Sep 30, 2024: cash n/a, total assets $2.47M, total liabilities n/a, shareholders' equity $803K

What is HYEX's revenue?

HEALTHY EXTRACTS INC. reported $6.29M of revenue over its last four quarters, through June 30, 2026.

Is HYEX profitable?

No. HEALTHY EXTRACTS INC. lost $879K over the last four quarters.

HYEX ownership and insider trades · All stocks